MedTrace Logo

Evaluation of Scanoskin for the Assessment of Vitiligo

NCT03133871 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2019-09-30

No results posted yet for this study

Summary

The aim of this study is to establish whether the use of a special digital camera (SIAscopy) can provide an accurate and reliable measure of vitiligo which is at least equivalent to the current gold standard of planimetry. If so, SIAscopy could be used as an objective diagnostic and prognostic tool in the management of vitiligo patients within dermatology departments and allow a fair and accurate assessment of new potential treatments.

Conditions

  • Vitiligo

Sponsors & Collaborators

  • Chelsea and Westminster NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Lucy J Thomas, MBChB · Chelsea and Westminster Hospital NHS Trust

  • Declan Colllins, MBBS · Chelsea and Westminster Hospital NHS Trust

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2018-11-20
Completion
2018-11-20

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03133871 on ClinicalTrials.gov